Skip to content

Total debt at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$509M+37.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.68M-13.3%
Avanos Medical logo
Avanos MedicalAVNS
$138.4M-1.8%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$411.18M+15.3%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$40.9M+26.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$40.5M-15.9%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $5.24M.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s total debt?
Collegium Pharmaceutical, Inc. (COLL) reported total debt of $5.24M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s total debt changed year-over-year?
Collegium Pharmaceutical, Inc.'s total debt decreased by 19.5% year-over-year, from $6.5M to $5.24M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s total debt?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s total debt has grown at a -10.2% compound annual growth rate (CAGR), from $9.5M to $5.54M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.